{"id":105655,"date":"2023-07-27T15:53:38","date_gmt":"2023-07-27T10:23:38","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=105655"},"modified":"2023-07-27T15:53:40","modified_gmt":"2023-07-27T10:23:40","slug":"pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/","title":{"rendered":"Pharma stock jumps 6.6% after company&#8217;s net profit increases by 26% in Q1"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1490316676\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1389222168\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/SYNGENE\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Syngene International<\/a><\/strong>, Biocon\u2019s subsidiary and India\u2019s first Contract Research Organization (CRO) offers end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS).\u00a0<\/p><p>The company reported a 26.39 percent increase in its consolidated net profit for the June quarter (Q1FY24) at \u20b9 808.10, a compared to \u20b9 644.50 crores in the corresponding quarter last year. Its revenue grew by 25.38 percent to \u20b9 808.10 crores as compared to \u20b9 644.50 crores in the same quarter last year.&nbsp;<\/p><p>Three important events took place in the April to June quarter. Syngene International announced the acquisition of a biologics manufacturing facility in Bangalore from Stelis Biopharma; the company received regulatory approval for the commercial manufacturing plant in Mangalore from the US Food and Drug Administration (USFDA) and it acquired additional land in Hyderabad to support further growth.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-480219817\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene International, said &#8220;First quarter performance was strong, led by development and manufacturing services and well supported by our research divisions: Discovery Services and the Dedicated Centers.&#8221;&nbsp;<\/p><p>Shares of the company settled at \u20b9 810.00 apiece on Thursday. In the past year, the company\u2019s share price increased by 170 percent from \u20b9 573.10 levels. An investment of \u20b9 1 lakh in the company\u2019s shares one year ago would be worth \u20b9 2.70 lakhs today!&nbsp;<\/p><p>With a market capitalization of \u20b9 30,436 crores, Syngene International is a mid-cap company. It has a low return on equity of 13.43 percent and an ideal debt-to-equity ratio of 0.23. Its shares were trading at a price-to-earnings ratio (P\/E) of 63.42, which is higher than the industry P\/E of 30.91, indicating that the stock might be overvalued as compared to its peers.&nbsp;<\/p><p>The company\u2019s promoters hold a 54.80 percent stake in it, followed by foreign institutions with 23.19 percent, retail investors with 12.58 percent, mutual funds with 8.58 percent and other domestic institutions with 0.85 percent.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Simran Bafna&nbsp;<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer.png\" alt=\"\" class=\"wp-image-26306\" width=\"256\" height=\"256\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-792339427\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.&nbsp; Syngene International, Biocon\u2019s subsidiary and India\u2019s [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":82826,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[3047,5890,3046,948,936,10296,10298,10295,10297],"class_list":["post-105655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-pharma-stocks","tag-pharma-stocks-latest-news","tag-pharma-stocks-to-buy","tag-stock-market","tag-stock-market-news","tag-syngene-international-latest-news","tag-syngene-international-q1-results-2023","tag-syngene-international-share-price","tag-why-is-syngene-international-share-increasing"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 6.6% after company&#039;s net profit increases by 26% in Q1 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 6.6% after company&#039;s net profit increases by 26% in Q1\" \/>\n<meta property=\"og:description\" content=\"Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-27T10:23:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-27T10:23:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/\",\"name\":\"Pharma stock jumps 6.6% after company's net profit increases by 26% in Q1 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"datePublished\":\"2023-07-27T10:23:38+00:00\",\"dateModified\":\"2023-07-27T10:23:40+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 6.6% after company&#8217;s net profit increases by 26% in Q1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 6.6% after company's net profit increases by 26% in Q1 - Trade Brains Features","description":"Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 6.6% after company's net profit increases by 26% in Q1","og_description":"Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-07-27T10:23:38+00:00","article_modified_time":"2023-07-27T10:23:40+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/","name":"Pharma stock jumps 6.6% after company's net profit increases by 26% in Q1 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","datePublished":"2023-07-27T10:23:38+00:00","dateModified":"2023-07-27T10:23:40+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of the listed contract research and manufacturing services arm of Biocon gained 6.6 percent on Thursday\u2019s intraday trades to reach a fresh 52-week high of \u20b9 813.00 apiece on the National Stock Exchange (NSE) after the company reported robust results for the June quarter (Q1) of FY 2023-24.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-6-6-after-companys-net-profit-increases-by-26-in-q1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 6.6% after company&#8217;s net profit increases by 26% in Q1"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=105655"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105655\/revisions"}],"predecessor-version":[{"id":105656,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105655\/revisions\/105656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/82826"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=105655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=105655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=105655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}